tiprankstipranks
Trending News
More News >
Healthcare Realty Trust (HR)
NYSE:HR
Advertisement

Healthcare Realty Trust (HR) AI Stock Analysis

Compare
609 Followers

Top Page

HR

Healthcare Realty Trust

(NYSE:HR)

Rating:61Neutral
Price Target:
$17.50
▼(-3.10% Downside)
Healthcare Realty Trust's overall stock score is driven by strong technical momentum and positive corporate events, which are offset by challenges in financial performance and valuation. The company's strategic initiatives and improved cash flow management are promising, but persistent profitability issues and valuation concerns weigh on the score.
Positive Factors
Earnings Growth
The company's new 3-year plan forecasts solid 10% earnings growth driven by core growth, lease-up, and cost savings.
Financial Performance
The 2Q25 results beat expectations with strong same-store net operating income driven by solid leasing.
Leadership
Scott is expected to bolster HR's leadership team.
Negative Factors
Dividend Challenges
The dividend payout remained challenged at 107%.
Dividend Policy
A potential ~20% dividend cut is likely towards a benchmark 80% AFFO payout ratio.
Guidance Expectations
Guidance maintained below the Street's expectations for normalized FFO.

Healthcare Realty Trust (HR) vs. SPDR S&P 500 ETF (SPY)

Healthcare Realty Trust Business Overview & Revenue Model

Company DescriptionHealthcare Realty Trust (HR) is a real estate investment trust (REIT) that focuses on acquiring, owning, and managing healthcare facilities across the United States. The company primarily invests in outpatient facilities, medical office buildings, and other healthcare-related properties, catering to the growing demand for healthcare services. By providing high-quality real estate solutions in the healthcare sector, HR aims to create value for its shareholders while supporting the needs of healthcare providers and patients.
How the Company Makes MoneyHealthcare Realty Trust generates revenue primarily through leasing its properties to healthcare providers, such as hospitals, outpatient clinics, and physician practices. The company earns rental income from long-term leases, which typically provide stable and predictable cash flows. Additionally, HR may benefit from property appreciation and the increasing demand for healthcare services, leading to higher occupancy rates and rental rates. The company also engages in acquisitions of new properties, which can enhance its portfolio and revenue potential. Key partnerships with healthcare providers and a focus on prime locations further contribute to its earnings, as these factors help ensure sustained demand for its real estate assets.

Healthcare Realty Trust Earnings Call Summary

Earnings Call Date:Jul 31, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mix of strong financial performance and strategic initiatives with positive outcomes in leasing and occupancy improvements. However, challenges remain with dividend reductions, high cap rates on dispositions, and underperformance in certain asset portfolios. The strategic plan aims to address these issues, but the immediate impact is mixed.
Q2-2025 Updates
Positive Updates
Strong Financial Performance
Normalized FFO was $0.41 per share, a $0.02 sequential increase. FAD was $0.33 per share, a $0.04 sequential increase. Same-store NOI growth was 5.1%, the highest in 9 years, with a 280 basis point sequential increase.
Occupancy and Leasing Success
Same-store occupancy increased to 90%, a 40 basis point sequential increase. The company had the second highest new leasing quarter in the last 3 years with nearly 1.5 million square feet of leases executed.
Balance Sheet Improvement
Successful renewal of the revolver and extended tenor of term loans. Net debt to adjusted EBITDA improved to 6x, with an expectation to decrease into the mid-5s by year-end.
Strategic Plan Implementation
Significant organizational restructuring and a focus on operations-oriented culture. Introduction of Healthcare Realty 2.0 with 5 key action items aimed at improved governance, restructuring, portfolio optimization, capital allocation, and balance sheet improvements.
Negative Updates
Dividend Reduction
Dividend was reduced by 23% to $0.24 per share to alleviate financial pressures and reallocate capital for reinvestment.
High Disposition Cap Rates
Disposition portfolio expected to close in 2025 at a blended cap rate of 7%, indicating potential challenges in maintaining asset value.
Underperformance of Lease-Up Portfolio
Lease-up portfolio performance lagged with current occupancy at 70% and NOI margins at 55%. Rents are nearly 20% below market due to underinvestment and deteriorated local relationships.
Company Guidance
During the Healthcare Realty Second Quarter 2025 Earnings Conference Call, the company provided detailed guidance and metrics reflecting its strategic plan and financial performance. Key metrics included a $0.41 normalized FFO per share, marking a $0.02 sequential increase, and a $0.33 FAD per share, up by $0.04 sequentially. The same-store occupancy improved to 90%, a 40-basis point sequential increase, while same-store NOI growth was at 5.1%, a 280-basis point sequential increase. The company's net debt to adjusted EBITDA ratio was reported at 6x. Additionally, year-to-date sales reached $211 million at a blended 6.2% cap rate, with over $700 million of additional assets under contract or LOI. The company highlighted plans to invest $300 million over three years into the lease-up portfolio, targeting $50 million of incremental NOI. Healthcare Realty also announced a dividend reduction by 23% to $0.24 per share quarterly, aiming to reinvest $100 million annually into its portfolio. The strategic plan focuses on improved corporate governance, organizational restructuring, portfolio optimization, reprioritizing capital allocation, and an improved balance sheet, with a target to reduce net debt-to-EBITDA to mid-5x by year-end.

Healthcare Realty Trust Financial Statement Overview

Summary
Healthcare Realty Trust exhibits strengths in cash flow management with positive free cash flow growth and strong EBITDA margins. However, persistent net losses and high operational expenses undermine overall profitability, affecting the financial health of the company.
Income Statement
42
Neutral
The company has shown a declining revenue trend with a negative revenue growth rate in recent years. The gross profit margin for the TTM is at 47.0%, indicating a strong ability to manage direct costs. However, the net profit margin is significantly negative due to ongoing net losses, suggesting challenges in managing operational and other expenses. The EBIT and EBITDA margins are 15.1% and 61.7% respectively for the TTM, indicating some operational efficiency but not enough to cover all expenses, leading to net losses.
Balance Sheet
55
Neutral
The debt-to-equity ratio has improved to 0.06 in the TTM from 0.95 in the previous year, indicating reduced leverage. The return on equity is negative due to net losses, impacting shareholder returns. The equity ratio stands at 48.4%, reflecting a balanced asset financing between liabilities and equity.
Cash Flow
60
Neutral
Free cash flow has shown growth, with a positive free cash flow growth rate in the TTM. The operating cash flow to net income and free cash flow to net income ratios are positive, indicating that despite net losses, the company generates sufficient cash flows from operations to cover its investments and financing needs.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.22B1.25B1.34B932.64M534.82M499.63M
Gross Profit579.51M772.59M112.62M588.60M322.54M303.12M
EBITDA607.44M295.55M780.51M555.62M287.60M274.18M
Net Income-391.06M-654.49M-278.26M-106.00M14.32M19.19M
Balance Sheet
Total Assets10.50B10.65B12.64B13.85B4.26B3.81B
Cash, Cash Equivalents and Short-Term Investments25.72M68.92M25.70M60.96M13.18M15.30M
Total Debt5.10B4.96B5.30B5.70B1.92B1.71B
Total Liabilities5.35B5.35B5.71B6.17B2.07B1.86B
Stockholders Equity5.08B5.23B6.82B7.57B2.19B1.95B
Cash Flow
Free Cash Flow205.53M252.64M268.79M109.20M131.94M376.13M
Operating Cash Flow473.25M501.62M499.82M272.75M232.63M470.09M
Investing Cash Flow920.65M900.92M349.14M1.63B-562.47M-555.17M
Financing Cash Flow-1.39B-1.36B-884.22M-1.86B327.72M99.72M

Healthcare Realty Trust Technical Analysis

Technical Analysis Sentiment
Positive
Last Price18.06
Price Trends
50DMA
16.30
Positive
100DMA
15.51
Positive
200DMA
15.78
Positive
Market Momentum
MACD
0.42
Negative
RSI
77.39
Negative
STOCH
91.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HR, the sentiment is Positive. The current price of 18.06 is above the 20-day moving average (MA) of 16.91, above the 50-day MA of 16.30, and above the 200-day MA of 15.78, indicating a bullish trend. The MACD of 0.42 indicates Negative momentum. The RSI at 77.39 is Negative, neither overbought nor oversold. The STOCH value of 91.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HR.

Healthcare Realty Trust Risk Analysis

Healthcare Realty Trust disclosed 42 risk factors in its most recent earnings report. Healthcare Realty Trust reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Healthcare Realty Trust Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$7.61B28.438.36%3.68%50.84%104.44%
79
Outperform
$3.67B24.6610.49%4.59%6.87%7.23%
74
Outperform
$4.56B25.036.66%6.31%6.89%240.70%
70
Neutral
$7.29B-1.51%2.34%11.62%
63
Neutral
$7.09B13.59-0.50%6.85%4.08%-25.24%
61
Neutral
$6.15B-7.59%6.48%-7.16%23.40%
49
Neutral
$2.67B-25.97%6.94%27.66%18.03%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HR
Healthcare Realty Trust
18.06
1.30
7.76%
NHI
National Health Investors
78.40
-0.23
-0.29%
SBRA
Sabra Healthcare REIT
19.03
2.81
17.32%
MPW
Medical Properties
4.61
-0.13
-2.74%
CTRE
CareTrust REIT
33.94
5.28
18.42%
AHR
American Healthcare REIT, Inc.
42.73
21.08
97.37%

Healthcare Realty Trust Corporate Events

Executive/Board ChangesPrivate Placements and FinancingBusiness Operations and StrategyFinancial Disclosures
Healthcare Realty Trust Reports Q2 2025 Financial Results
Neutral
Jul 31, 2025

Healthcare Realty Trust reported its second-quarter 2025 results, highlighting a GAAP net loss of $0.45 per share and a normalized FFO of $0.41 per share. The company saw improvements in operating metrics, such as a 5.1% growth in cash NOI and a 40 basis point increase in occupancy to 90%. The company executed new and renewal leases totaling 1.5 million square feet and completed asset sales worth $182.4 million. Leadership changes included the appointment of Peter Scott as President and CEO, and a reduction in board size from 12 to 7 members. The company also extended its $1.5 billion revolving credit facility to mature in 2030 and published a strategic plan to enhance shareholder value.

Private Placements and FinancingBusiness Operations and Strategy
Healthcare Realty Trust Announces New Credit Facility Agreement
Positive
Jul 31, 2025

On July 31, 2025, Healthcare Realty Trust announced a new credit facility agreement, effective July 25, 2025, which replaces its existing credit arrangements. This new facility includes a $1.5 billion unsecured revolving credit and five term loan tranches totaling $1.115 billion, with extended maturity dates and interest rates tied to the borrower’s credit ratings. The agreement aims to enhance financial flexibility and maintain favorable credit terms, potentially impacting the company’s financial operations and its stakeholders.

Executive/Board ChangesBusiness Operations and Strategy
Healthcare Realty Trust Announces Board Restructuring
Positive
Jun 23, 2025

On June 18, 2025, Healthcare Realty Trust announced the voluntary retirement of five directors from its Board, reducing its size from 12 to 7 members. This strategic move aligns the Board’s size with industry standards and reinforces the company’s commitment to best practices in corporate governance. The changes are expected to enhance shareholder engagement and drive value, with the remaining directors focused on strengthening stakeholder relationships and capitalizing on strong industry fundamentals.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2025